Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.027 | 0.7 |
mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |